Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03953898
Title Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC Irvine Health/Chao Family Comprehensive Cancer Center Orange California 92868 United States Details
Yale University New Haven Connecticut 06520 United States Details
UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables Florida 33146 United States Details
UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach Florida 33442 United States Details
University of Miami Miller School of Medicine-Sylvester Cancer Center Miami Florida 33136 United States Details
UM Sylvester Comprehensive Cancer Center at Plantation Plantation Florida 33324 United States Details
University of Maryland/Greenebaum Cancer Center Baltimore Maryland 21201 United States Details
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center Lebanon New Hampshire 03756 United States Details
Wake Forest University at Clemmons Clemmons North Carolina 27012 United States Details
Wake Forest Baptist Health - Wilkes Medical Center Wilkesboro North Carolina 28659 United States Details
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field